For first-degree relatives of patients with Crohn disease, increased antibody response is associated with subsequent risk for CD.

This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid limited options. The FDA has granted orphan drug designation (ODD) to ARB1002, ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. | After netting a $361 million series C funding round in October, ...

Pancreatic cancer has long resisted immunotherapy, but scientists have uncovered a subtle way these tumors evade immune attack. By exploiting a sugar-based “don’t harm me” signal normally used by ...

A specially engineered antibody that can infiltrate kidney cysts has shown the ability to block key growth signals driving polycystic kidney disease. Early mouse studies suggest it may halt or even ...

Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according ...

An international research team led by the University of Cologne has discovered an antibody that could advance the fight against HIV. The newly identified antibody 04_A06 proved to be particularly ...

Some people vaccinated against COVID-19 initially acquire strong levels of neutralizing antibodies but then experience rapid declines. Measuring immunoglobulin A antibody titers post-vaccination could ...